No one understands technology like Twitter and Square CEO Jack Dorsey. That’s according to Nate Checketts, co-founder and head of smart apparel maker Rhone, who got a chance to spend some time with the tech exec over the course of a year. “We started talking about wearable technology, and he said something that really stuck with me. Technology is something that should really fade into the background,” Checketts said in an interview on Cheddar Monday. “If it’s done well...you shouldn’t even have to think that you’re wearing it.” Checketts said he’s carried this mindset with him when Rhone designed its GoldFusion line. The technology infuses nanoparticles of gold with fabric. Rhone claims that GoldFusion allows its brand to absorb liquid three times faster than the industry standard and says that it remains 99 percent effective even after 100 washes. “The technology is doing its work without you having to do anything,” he told “Opening Bell.” “With this, it just works. You put it on and it works” he said.

Share:
More In Business
Crowdbotics Raises $22M Series A to Enable Anyone to Turn Ideas Into Apps
Low-code app development platform Crowdbotics raised $22 million in a Series A funding round led by Jackson Square Ventures. Crowdbotics has helped more than 14,000 customers launch apps without having to learn how to code. The company can offer a team of expert developers to help companies launch custom apps, or provide the means for companies to develop apps themselves. Crowdbotics CEO Anand Kulkarni joined Cheddar News' Closing Bell to discuss.
McDonald's Posts Q4 Earnings Miss; McPlant Burger Takes Off
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna's Chief Medical Officer on Omicron Booster Trial, Annual Shots
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
Load More